PHF6 and cancer: Similarly, using data from the TCGA and GTEx databases, PHF6 expression was significantly higher in most cancer types, except for kidney cancer, ovarian serous cystadenocarcinoma (OV), and adrenocortical carcinoma (ACC) (Figure 1B).